Day Range8.870 - 9.120 | 52 Wk Range4.070 - 20.475 | Open / Close8.980 / - | Float / Outstanding141.687M / 142.110M |
Vol / Avg.846.166K / 3.146M | Mkt Cap1.280B | P/E- | 50d Avg. Price6.000 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
Day Range8.870 - 9.120 | 52 Wk Range4.070 - 20.475 | Open / Close8.980 / - | Float / Outstanding141.687M / 142.110M |
Vol / Avg.846.166K / 3.146M | Mkt Cap1.280B | P/E- | 50d Avg. Price6.000 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.170 | -0.060 | 0.1100 | ||||
REV | 36.180M | 55.779M | 19.599M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
There are no as such competitors for Aurinia Pharmaceuticals.
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 22.15% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.005 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
There is no upcoming split for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
Day Range8.870 - 9.120 | 52 Wk Range4.070 - 20.475 | Open / Close8.980 / - | Float / Outstanding141.687M / 142.110M |
Vol / Avg.846.166K / 3.146M | Mkt Cap1.280B | P/E- | 50d Avg. Price6.000 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.170 | -0.060 | 0.1100 | ||||
REV | 36.180M | 55.779M | 19.599M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
There are no as such competitors for Aurinia Pharmaceuticals.
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 22.15% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.005 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
There is no upcoming split for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
Day Range8.870 - 9.120 | 52 Wk Range4.070 - 20.475 | Open / Close8.980 / - | Float / Outstanding141.687M / 142.110M |
Vol / Avg.846.166K / 3.146M | Mkt Cap1.280B | P/E- | 50d Avg. Price6.000 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.170 | -0.060 | 0.1100 | ||||
REV | 36.180M | 55.779M | 19.599M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
There are no as such competitors for Aurinia Pharmaceuticals.
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 22.15% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.005 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
There is no upcoming split for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
Day Range8.870 - 9.120 | 52 Wk Range4.070 - 20.475 | Open / Close8.980 / - | Float / Outstanding141.687M / 142.110M |
Vol / Avg.846.166K / 3.146M | Mkt Cap1.280B | P/E- | 50d Avg. Price6.000 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.170 | -0.060 | 0.1100 | ||||
REV | 36.180M | 55.779M | 19.599M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
There are no as such competitors for Aurinia Pharmaceuticals.
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 22.15% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.005 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
There is no upcoming split for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
Day Range8.870 - 9.120 | 52 Wk Range4.070 - 20.475 | Open / Close8.980 / - | Float / Outstanding141.687M / 142.110M |
Vol / Avg.846.166K / 3.146M | Mkt Cap1.280B | P/E- | 50d Avg. Price6.000 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.170 | -0.060 | 0.1100 | ||||
REV | 36.180M | 55.779M | 19.599M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
There are no as such competitors for Aurinia Pharmaceuticals.
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 22.15% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.005 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
There is no upcoming split for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
Day Range8.870 - 9.120 | 52 Wk Range4.070 - 20.475 | Open / Close8.980 / - | Float / Outstanding141.687M / 142.110M |
Vol / Avg.846.166K / 3.146M | Mkt Cap1.280B | P/E- | 50d Avg. Price6.000 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.170 | -0.060 | 0.1100 | ||||
REV | 36.180M | 55.779M | 19.599M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
There are no as such competitors for Aurinia Pharmaceuticals.
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 22.15% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.005 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
There is no upcoming split for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
Day Range8.870 - 9.120 | 52 Wk Range4.070 - 20.475 | Open / Close8.980 / - | Float / Outstanding141.687M / 142.110M |
Vol / Avg.846.166K / 3.146M | Mkt Cap1.280B | P/E- | 50d Avg. Price6.000 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.170 | -0.060 | 0.1100 | ||||
REV | 36.180M | 55.779M | 19.599M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
There are no as such competitors for Aurinia Pharmaceuticals.
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 22.15% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.005 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
There is no upcoming split for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
Day Range8.870 - 9.120 | 52 Wk Range4.070 - 20.475 | Open / Close8.980 / - | Float / Outstanding141.687M / 142.110M |
Vol / Avg.846.166K / 3.146M | Mkt Cap1.280B | P/E- | 50d Avg. Price6.000 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.170 | -0.060 | 0.1100 | ||||
REV | 36.180M | 55.779M | 19.599M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
There are no as such competitors for Aurinia Pharmaceuticals.
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 22.15% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.005 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
There is no upcoming split for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
Day Range8.870 - 9.120 | 52 Wk Range4.070 - 20.475 | Open / Close8.980 / - | Float / Outstanding141.687M / 142.110M |
Vol / Avg.846.166K / 3.146M | Mkt Cap1.280B | P/E- | 50d Avg. Price6.000 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float141.687M | EPS-0.830 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.170 | -0.060 | 0.1100 | ||||
REV | 36.180M | 55.779M | 19.599M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
There are no as such competitors for Aurinia Pharmaceuticals.
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by RBC Capital on Wednesday, January 4, 2023. The analyst firm set a price target for 11.00 expecting AUPH to rise to within 12 months (a possible 22.15% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $9.005 last updated Today at January 31, 2023 at 6:01 PM UTC.
There are no upcoming dividends for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.
There is no upcoming split for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.